Vimarsana
Biggest News Aggregation in the World

Mobility Workx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mobility Workx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mobility Workx Today - Breaking & Trending Today

Will "Compelling Merits" Institution Standard Lead To Rubber Stamp FWDs? - Patent - Vimarsana News

Will "Compelling Merits" Institution Standard Lead To Rubber Stamp FWDs? - Patent

If a PTAB panel finds "compelling merits" of unpatentability when making its initial institution decision, is there any realistic chance that same PTAB panel will reach a different result...

Source: mondaq.com
PTAB Bias Claims Not A Proper Basis For Constitutional Damages Claim, Rules Tennessee Judge - Patent - Vimarsana News

PTAB Bias Claims Not A Proper Basis For Constitutional Damages Claim, Rules Tennessee Judge - Patent

The Patent Trial and Appeal Board has seen a variety of challenges to the America Invents Act review regime since its inception,...

Source: mondaq.com
2022 Developments Shaping Patent Law - Vimarsana News

2022 Developments Shaping Patent Law

Tracking with this era’s continuation and uncertainty trends ― global supply chain disruption, innovation outpacing legislation, the unstoppable internet of things ― 2022 is expected to be another busy year in the world of patent litigation.

2022 Developments Shaping Patent Law - Vimarsana News

2022 Developments Shaping Patent Law

Tracking with this era’s continuation and uncertainty trends ― global supply chain disruption, innovation outpacing legislation, the unstoppable internet of things ― 2022 is expected to be another busy year in the world of patent litigation.

What does USPTO director review really change? - Vimarsana News

What does USPTO director review really change?

Ha Kung Wong at Venable and April Breyer Menon at April Breyer Consulting delve into the practical implications of the US Supreme Court’s ruling in US v Arthrex